Spine surgeons survey on attitudes regarding osteoporosis and osteomalacia screening and treatment for fractures, fusion surgery, and pseudoarthrosis
To access this article, please choose from the options below
FDA device/drug status: not applicable.
Author disclosures: SRG (royalties from DePuy Spine; stockholder at Spine Medica, Surgifile, Archus Orthopaedics, Biomerix, Cross Tree, Cytonics Corporation, Interventional Spine, Kyphon, Pioneer Surgical, Spinal Kinetics, SpineMark; consultant for Applied Spine Technology, Biomerix, Calcitec, Inc., Cytonics Corporation, Disc Dynamics, Exactech, Interventional Spine, Kyphon, Magnifi Group, NuVasive, Orthovita, Pioneer Surgical, Spinal Kinetics, Spine Mark, Spine Medica; speaker for Blackstone International, DePuy, EBI, Kyphon; member for scientific advisory board at Applied Spine Technology, Biomerix, Calcitec, Inc., Disc Dynamics, Kyphon, NuVasive, Spinal Kinetics, Spine Medica; and research support from Kyphon, DePuy, Inc., Synthes, EBI, Medtronics, NuVasive, Kyphon, Synthes Spine, DePuy, Medtronics, EBI, Abbott).
PII: S1529-9430(09)00216-2
doi:10.1016/j.spinee.2009.05.002
© 2009 Elsevier Inc. All rights reserved.
